There has been an array of important advice provided globally and nationally for managing clinical trials in these uncertain times. But synthesizing that information and understanding how to interpret and apply it can feel overwhelming for many. In this webinar hosted by PRAXIS, they will bring together that advice and help you to better understand which elements you can adopt (and adapt) and to reassure you that help and advice is at hand. It is critical at this time that we are all working together to ensure that clear and consistent information is being delivered and that we understand how that can be used to help support our clinical trials businesses and ensure the safety and well being of our trial participants.
Latest Resources
Latest Events
-
Trial Participants & COVID-19: considerations and strategies for running trials during the pandemic
-
Clinical Trials for COVID-19 Treatment and Prevention
-
Pharmacovigilance and Regulatory Affairs & COVID-19: considerations and strategies for running trials during the pandemic
-
Private Sector & COVID-19: considerations and strategies for running trials during the pandemic
-
Academics & COVID-19: considerations and strategies for running trials during the pandemic
-
Role of Clinical Trial Sponsors & COVID-19: considerations and strategies for running trials during the pandemic
-
Tweetchats with PRAXIS and ACTA
-
Ethics Committees and Governance & COVID-19: considerations and strategies for running trials during the pandemic
-
Jurisdictions: Federal/States & COVID-19: considerations and strategies for running trials during the pandemic
-
Peak Bodies and TGA & COVID-19: considerations and strategies for running trials during the pandemic